HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor

Kovacs, Jeffrey J., Murphy, Patrick J.M., Gaillard, Stéphanie, Zhao, Xuan, Wu, June-Tai, Nicchitta, Christopher V., Yoshida, Minoru, Toft, David O. +2 more·2005·Molecular Cell
DOI 10.1016/j.molcel.2005.04.021

Cited by (1,001)

Items 301–400 of 1,001

  1. Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma
    Mohamed A.Y. Abdel Malek, Sajjeev Jagannathan, Ehsan Malek, Douaa Mohammed Sayed, Sahar A. Elgammal, Hanan G. Abd El-Azeem, Nabila M. Thabet, James Joseph Driscoll · 2014 · Oncotarget
  2. Analysis of the Tau-Associated Proteome Reveals That Exchange of Hsp70 for Hsp90 Is Involved in Tau Degradation
    Andrea D. Thompson, Kenneth Matthew Scaglione, John R. Prensner, Anne T. Gillies, Arul M. Chinnaiyan, Henry Lauris Paulson, Umesh K. Jinwal, Chad A. Dickey, Jason E. Gestwicki · 2012 · ACS Chemical Biology
  3. Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
    Eunah Kim, William H. Bisson, Christiane V. Löhr, David E. Williams, Emily Ho, Roderick H. Dashwood, Praveen Rajendran · 2015 · Current Topics in Medicinal Chemistry
  4. Selective Raf inhibition in cancer therapy
    Vladimir Khazak, Igor A. Astsaturov, Ilya G. Serebriiskii, Erica A. Golemis · 2007 · Expert Opinion on Therapeutic Targets
  5. Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
    Zhang, Chao, Yang, Chunzhang, Feldman, Michael J., Wang, Herui, Pang, Ying, Maggio, Dominic M., Zhu, Dongwang, Nesvick, Cody L., Dmitriev, Pauline, Bullova, Petra et al. · 2017 · Oncotarget
  6. Targeting chaperones in transformed systems – a focus on Hsp90 and cancer
    Gabriela Chiosis · 2006 · Expert Opinion on Therapeutic Targets
  7. Chapter 4 Ciliary Tubulin and Its Post-Translational Modifications
    Jacek Gaertig, Dorota Włoga · 2008 · Current topics in developmental biology/Current Topics in Developmental Biology
  8. The use of diversity profiling to characterize chemical modulators of the histone deacetylases
    Leonard J. Blackwell, Jacqueline L. Norris, Carla M. Suto, William P. Janzen · 2008 · Life Sciences
  9. Regulation of Tat Acetylation and Transactivation Activity by the Microtubule-associated Deacetylase HDAC6
    Lihong Huo, Dengwen Li, Xiaoou Sun, Xingjuan Shi, Prasanthi Karna, Wei Yang, Min Liu, Wentao Qiao, Ritu Aneja, Jun Zhou · 2011 · Journal of Biological Chemistry
  10. HDAC inhibitor therapy in autoimmunity and transplantation
    Wayne W. Hancock, Tatiana Akimova, Ulf Henning Beier, Yujie Liu, Liqing Wang · 2012 · Annals of the Rheumatic Diseases
  11. GCN5-dependent acetylation of HIV-1 integrase enhances viral integration
    Mariaelena Terreni, Paola Valentini, Vania Liverani, María Inés Gutiérrez, Cristina Di Primio, Armida Di Fenza, Valentina Tozzini, Awatef Allouch, Alberto Albanese, Mauro Giacca et al. · 2010 · Retrovirology
  12. Ubiquitin in Influenza Virus Entry and Innate Immunity
    Alina Rudnicka, Yohei Yamauchi · 2016 · Viruses
  13. Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
    Chunzhang Yang, Shervin Rahimpour, Jie Lu, Karel Pacák, Barbara L. Ikejiri, Roscoe O. Brady, Zhengping Zhuang · 2012 · Proceedings of the National Academy of Sciences
  14. HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
    Emily Koeneke, Olaf Witt, Ina Oehme · 2015 · Cells
  15. The emerging role of lysine acetylation of non-nuclear proteins
    Pierre Close, Catherine Creppe, Magali Gillard, Aurélie Ladang, Jean-Paul Chapelle, Laurent Nguyen, Alain Chariot · 2010 · Cellular and Molecular Life Sciences
  16. Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor–resistant acute myeloid leukemia cells
    Warren C. Fiskus, Rekha Rao, Pravina Fernandez, Bryan E. Herger, Yonghua Yang, Jianguang Chen, Ravindra B Kolhe, Aditya Mandawat, Yongchao Wang, Rajeshree Joshi et al. · 2008 · Blood
  17. Interplay Between HDAC6 and Its Interacting Partners: Essential Roles in the Aggresome-Autophagy Pathway and Neurodegenerative Diseases
    Jin Yan · 2014 · DNA and Cell Biology
  18. Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders
    Rohan V. Gupta, Rashmi K. Ambasta, Pravir Kumar · 2020 · Life Sciences
  19. Complex neuroprotective and neurotoxic effects of histone deacetylases
    Elizabeth A. Thomas, Santosh R. D’Mello · 2018 · Journal of Neurochemistry
  20. Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities
    Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Fernanda Savacini Sagrillo, María Laura Bolognesi, Carlos Alberto Manssour Fraga · 2020 · Medicinal Research Reviews
  21. Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance
    Jian Zhang, Houde Li, Yu Liu, Kejia Zhao, Shiyou Wei, Eric T. Sugarman, Lunxu Liu, Gao Zhang · 2022 · Cells
  22. Chapter 6 Mechanisms Regulating the Susceptibility of Hematopoietic Malignancies to Glucocorticoid‐Induced Apoptosis
    Ronit Vogt Sionov, Rachel Spokoini, Shlomit Kfir‐Erenfeld, Orly Cohen, Eitan Yefenof · 2008 · Advances in cancer research
  23. Protein kinase CK2 regulates the formation and clearance of aggresomes in response to stress
    Masahiko Watabe, Toshio Nakaki · 2011 · Journal of Cell Science
  24. Microtubule Acetylation Through HDAC6 Inhibition Results in Increased Transfection Efficiency
    Erin E Vaughan, Richard Geiger, Aaron M Miller, Phoebe L Loh-Marley, Takayoshi Suzuki, Naoki Miyata, David A. Dean · 2008 · Molecular Therapy
  25. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90
    Ping Liu, Ji Xiao, Yiliang Wang, Xiaowei Song, Lianzhou Huang, Zhe Ren, Kaio Kitazato, Yifei Wang · 2021 · Molecular Medicine
  26. Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
    Lien Dejager, Sofie Vandevyver, Ιωάννα Πέττα, Claude Libert · 2013 · Cytokine & Growth Factor Reviews
  27. Impact of protein acetylation in inflammatory lung diseases
    Kazuhiro Ito, Catherine E. Charron, Ian Michael Adcock · 2007 · Pharmacology & Therapeutics
  28. Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression
    Alejandra G. Erlejman, Mariana Lagadari, Judith Toneatto, Graciela Piwien‐Pilipuk, Mario D. Galigniana · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  29. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
    Tint Lwin, Xiaohong Zhao, Fengdong Cheng, Xinwei Zhang, Andy Huang, Bijal Dinesh Shah, Yizhuo Zhang, Lynn C. Moscinski, Yong Sung Choi, Alan P. Kozikowski et al. · 2013 · Journal of Clinical Investigation
  30. Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010–2020)
    Li, Yunheng, Sang, Shenghu, Ren, Weijie, Pei, Yuqiong, Bian, Yaoyao, Chen, Yao, Sun, Haopeng · 2021 · European Journal of Medicinal Chemistry
  31. Identification of a Key Lysine Residue in Heat Shock Protein 90 Required for Azole and Echinocandin Resistance in Aspergillus fumigatus
    Lamoth, Frédéric, Juvvadi, Praveen R., Soderblom, Erik J., Moseley, M. Arthur, Asfaw, Yohannes G., Steinbach, William J. · 2014 · Antimicrobial Agents and Chemotherapy
  32. First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation
    Kairui Yue, Simin Sun, Geng Jia, Mengting Qin, Xiaohan Hou, C. James Chou, Chao Huang, Xiaoyang Li · 2022 · Journal of Medicinal Chemistry
  33. Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: Circadian rhythm-associated alterations of glucocorticoid actions in target tissues
    Tomoshige Kino, George Panagiotis Chrousos · 2010 · Molecular and Cellular Endocrinology
  34. Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors
    Shipeng He, Guoqiang Dong, Zhibin Wang, Wei Chen, Yahui Huang, Zhengang Li, Yan Jiang, Na Liu, Jianzhong Yao, Zhenyuan Miao et al. · 2015 · ACS Medicinal Chemistry Letters
  35. 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes
    Hsueh‐Yun Lee, Sheng-Jun Fan, Fang-I Huang, Hsin-Yi Chao, Kai‐Cheng Hsu, Tony Eight Lin, Teng‐Kuang Yeh, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang et al. · 2018 · Journal of Medicinal Chemistry
  36. Romidepsin and Belinostat Synergize the Antineoplastic Effect of Bortezomib in Mantle Cell Lymphoma
    Luca Paoluzzi, Luigi Scotto, Enrica Marchi, Jasmine M. Zain, Venkatraman Seshan, Owen A. O’Connor · 2010 · Clinical Cancer Research
  37. HDAC 6 at the Intersection of Neuroprotection and Neurodegeneration
    Constantin van Outryve d’Ydewalle, Elke Bogaert, Ludo Van Den Bosch · 2012 · Traffic
  38. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
    Jiacheng Ma, XiaoJiao Huo, Matthew B. Jarpe, Annemieke Kavelaars, Cobi J. Heijnen · 2018 · Acta Neuropathologica Communications
  39. Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?
    Angela De Simone, Andrea Milelli · 2019 · ChemMedChem
  40. The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
    Hu Chen, Mu Zhang, Niko Moses, Cong-li Hu, Lisa Polin, Wei Chen, Hyejeong Jang, Joshua R. Heyza, Agnes Malysa, Joseph A. Caruso et al. · 2020 · Cell Death and Disease
  41. Mechanism for ubiquitylation of the leukemia fusion proteins AML1‐ETO and PML‐RARα
    Oliver Holger Krämer, Sylvia Müller, Marc Buchwald, Sigrid Reichardt, Thorsten Heinzel · 2007 · The FASEB Journal
  42. Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia‐Inducible Factors
    Shuyang Chen, Nianli Sang · 2010 · BioMed Research International
  43. Histone deacetylases in viral infections
    Georges Herbein, Daniel Wendling · 2010 · Clinical Epigenetics
  44. Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
    Jiaqi Liu, Jianying Gu, Zihao Feng, Yanhong Yang, Ningwen Zhu, Weiyue Lu, Fazhi Qi · 2016 · Journal of Translational Medicine
  45. The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
    P Garrido Castro, Eddy H.J. Van Roon, Sandra S. Pinhanços, Luca Trentin, Pauline Schneider, Mark JB Kerstjens, Geertruy te Kronnie, Olaf T Heidenreich, Rob Pieters, Ronald W. Stam · 2017 · Leukemia
  46. Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
    Karrune V. Woan, Eva Sahakian, Eduardo M. Sotomayor, Edward Seto, Alejandro Villagra · 2011 · Immunology and Cell Biology
  47. Crosstalk between the ubiquitin–proteasome system and autophagy in a human cellular model of Alzheimer's disease
    Valentina Cecarini, Laura Bonfili, Massimiliano Cuccioloni, Matteo Mozzicafreddo, Giacomo Rossi, Laura Buizza, Daniela Letizia Uberti, Mauro Angeletti, Anna Maria Eleuteri · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  48. Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells
    William Brazelle, Jenny M. Kreahling, Jennifer Y. Gemmer, Yihong Ma, William Douglas Cress, Eric B. Haura, Soner Altiok · 2010 · PLoS ONE
  49. Epigenetic regulation of androgen receptor signaling in prostate cancer
    Lina Gao, Joshi J. Alumkal · 2010 · Epigenetics
  50. Hypoxia inducible factor-1α in human emphysema lung tissue
    Masanori Yasuo, Shiro Mizuno, Donatas Kraskauskas, Harm Jan Bogaard, Ramesh Natarajan, Carlyne D. Cool, Martin R. Zamora, Norbert Felix Voelkel · 2010 · European Respiratory Journal
  51. PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition
    Z Meng, L-F Jia, Y‐H. Gan · 2015 · Oncogene
  52. Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
    Apostolia Maria Tsimberidou, Philip A. Beer, Carrie Cartwright, Cara Haymaker, Henry Hiep Vo, Simin Kiany, Alexander Cecil, James Dow, Kemal Haque, Franck A. Silva et al. · 2021 · Clinical Cancer Research
  53. TDP‐43 and FUS/TLS: cellular functions and implications for neurodegeneration
    Fabienne C. Fiesel, Philipp J. Kahle · 2011 · FEBS Journal
  54. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
    Toshiki Mawatari, Itasu Ninomiya, Masafumi Inokuchi, SHINICHI HARADA, Hironori Hayashi, Katsunobu Oyama, Isamu Makino, Hisatoshi Nakagawara, Tomoharu Miyashita, Hidehiro Tajima et al. · 2015 · International Journal of Oncology
  55. Identification and Structure–Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors
    Renato Ferreira de Freitas, Rachel Harding, Ivan Franzoni, Mani Ravichandran, Mandeep Kaur Mann, Hui Ouyang, Mark Lautens, Vijayaratnam Santhakumar, C.H. Arrowsmith, Matthieu Schapira · 2018 · Journal of Medicinal Chemistry
  56. Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma
    Xiaopeng Peng, Ling Li, Jingxuan Chen, Yichang Ren, Jin Liu, Ziwen Yu, Hao Cao, Jianjun Chen · 2022 · Journal of Medicinal Chemistry
  57. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein
    G Yang, Mary Ann Thompson, Stephen J. Brandt, Scott W. Hiebert · 2006 · Oncogene
  58. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model
    Ren, Yuan, Su, Xinming, Kong, Lingfei, Li, Menglu, Zhao, Xuan, Yu, Na, Kang, Jian · 2016 · Inflammation Research
  59. Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism
    Mengyuan Huang, Jiangkun Huang, Yongcheng Zheng, Qiu Sun · 2019 · European Journal of Medicinal Chemistry
  60. Association of Estrogen Receptor α and Histone Deacetylase 6 Causes Rapid Deacetylation of Tubulin in Breast Cancer Cells
    Kotaro Azuma, Tomohiko Urano, Kuniko Horie‐Inoue, Shin‐ichi Hayashi, Ryuichi Sakai, Yasuyoshi Ouchi, Satoshi Inoue · 2009 · Cancer Research
  61. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone
    Douglas R. Hurst, Alka Mehta, Blake P. Moore, Pushkar A. Phadke, William J. Meehan, Mary Ann Accavitti, Lalita A. Shevde, James E. Hopper, Yi Xie, Danny R. Welch et al. · 2006 · Biochemical and Biophysical Research Communications
  62. HSP90 multi-functionality in cancer
    Zarema Albakova · 2024 · Frontiers in Immunology
  63. Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells
    Jane Ying-Chieh Lee, Ching-Wen Kuo, Shing-Ling Tsai, Siao Muk Cheng, Shang‐Hung Chen, Hsiu-Han Chan, Chun-Hui Lin, Kun-Yuan Lin, Chien‐Feng Li, Jagat R. Kanwar et al. · 2016 · Frontiers in Pharmacology
  64. Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy
    An Verheyen, Eve Peeraer, Rony Nuydens, Joke Dhondt, Koen Poesen, Isabel Pintelon, Anneleen Daniels, Jean‐Pierre Timmermans, Theo Frans Meert, Peter Carmeliet et al. · 2012 · Brain
  65. Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity
    Linlin Zhang, Shanshan Liu, Ningning Liu, Yong Zhang, Min Liu, Dengwen Li, Edward Seto, Tso‐Pang Yao, Wenqing Shui, Jun Zhou · 2014 · Protein & Cell
  66. Subcellular Localization of Class II HDAs in Arabidopsis thaliana: Nucleocytoplasmic Shuttling of HDA15 Is Driven by Light
    Malona V. Alinsug, Fang Fang Chen, Ming Luo, Ready Tai, Liwen Jiang, Keqiang Wu · 2012 · PLoS ONE
  67. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
    Adhikari, Nilanjan, Jha, Tarun, Ghosh, Balaram · 2021 · Journal of Medicinal Chemistry
  68. The glucocorticoid receptor signalling in breast cancer
    Paraskevi Moutsatsou, Athanasios G. Papavassiliou · 2007 · Journal of Cellular and Molecular Medicine
  69. Targeting histone deacetyalses in the treatment of B- and T-cell malignancies
    Jasmine M. Zain, Owen A. O’Connor · 2010 · Investigational New Drugs
  70. HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
    Yue, Lanzhu, Sharma, Vasundhara, Horvat, Nathan P., Akuffo, Afua A., Beatty, Matthew S., Murdun, Cem, Colin, Christelle, Billington, Julia M. R., Goodheart, William E., Sahakian, Eva et al. · 2020 · Blood
  71. Hdac6 regulates Tip60-p400 function in stem cells
    Poshen B. Chen, Jui‐Hung Hung, Taylor L. Hickman, Andrew H. Coles, James F. Carey, Zhiping Weng, Feixia Chu C, Thomas G. Fazzio · 2013 · eLife
  72. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation
    Shinji Toki, Kasia Goleniewska, Sara Reiss, Weisong Zhou, Dawn C. Newcomb, Melissa Harintho Bloodworth, Matthew T. Stier, Kelli Lynn Boyd, Vasiliy V. Polosukhin, Subramaniam Sriram et al. · 2016 · Thorax
  73. Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogaster
    Jian Chen, Xiaoying Shi, Ranjani Padmanabhan, Qiong Wang, Zhidan Wu, Susan C. Stevenson, Marc Hild, Dan Garza, Hao Li · 2007 · Genome Research
  74. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation
    Lucy X. Fan, Xinjian Li, Brenda S. Magenheimer, James P. Calvet, Xiaogang Li · 2011 · Kidney International
  75. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells
    Dengwen Li, Xiaodong Sun, Linlin Zhang, Bing Yan, Songbo Xie, Ruming Liu, Min Liu, Jun Zhou · 2014 · Protein & Cell
  76. Targeted inhibition of histone deacetylase 6 in inflammatory diseases
    Jie Ran, Jun Zhou · 2019 · Thoracic Cancer
  77. Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma
    Jennifer Effie Amengual, Sean Clark-Garvey, Matko Kalac, Luigi Scotto, Enrica Marchi, Ellen Neylon, Paul M. Johannet, Ying Wei, Jasmine M. Zain, Owen A. O’Connor · 2013 · Blood
  78. Interplay between histone deacetylases and autophagy ‐ from cancer therapy to neurodegeneration
    O Truee, Patrick Matthias · 2011 · Immunology and Cell Biology
  79. HDAC6 Deacetylase Activity Is Critical for Lipopolysaccharide-Induced Activation of Macrophages
    Bing Yan, Songbo Xie, Zhu Liu, Jie Ran, Yuanyuan Li, Jian Wang, Yang Yang, Jun Zhou, Dengwen Li, Min Liu · 2014 · PLoS ONE
  80. Contributions of Co-Chaperones and Post-Translational Modifications Towards Hsp90 Drug Sensitivity
    Annerleim Walton‐Diaz, Sahar Khan, Dimitra Bourboulia, Jane B. Trepel, Len Neckers, Mehdi Mollapour · 2013 · Future Medicinal Chemistry
  81. Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis
    Frédéric Lamoth, Praveen R. Juvvadi, William J. Steinbach · 2015 · Frontiers in Microbiology
  82. Therapeutic effects of histone deacetylase inhibitors on heart disease
    Pusoon Chun · 2020 · Archives of Pharmacal Research
  83. Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
    Aikaterini F. Giannopoulou, Athanassios D. Velentzas, Eumorphia G. Konstantakou, Margaritis Avgeris, Stamatia A. Katarachia, Nikolaos C. Papandreou, Nikolaos Kalavros, Vassiliki Mpakou, Vassiliki A. Iconomidou, Ema Anastasiadou et al. · 2019 · International Journal of Molecular Sciences
  84. The Heat Shock Protein 90-CDC37 Chaperone Complex Is Required for Signaling by Types I and II Interferons
    Limin Shang, Thomas B. Tomasi · 2005 · Journal of Biological Chemistry
  85. Histone Deacetylase Inhibitors Suppress TF-κB-dependent Agonist-driven Tissue Factor Expression in Endothelial Cells and Monocytes
    Jianguo Wang, Shawn A. Mahmud, Peter B. Bitterman, Yuqing Huo, Arne Slungaard · 2007 · Journal of Biological Chemistry
  86. Proteolysis targeting chimeras (PROTACs) for epigenetics research
    Anja Vogelmann, Dina Robaa, Wolfgang Sippl, Manfred Jung · 2020 · Current Opinion in Chemical Biology
  87. HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions
    Alexis Osseni, Aymeric Ravel‐Chapuis, Jean-Luc Thomas, Vincent Gache, Laurent Schaeffer, Bernard Jean Jasmin · 2020 · The Journal of Cell Biology
  88. Hsp90 regulates the Fanconi anemia DNA damage response pathway
    Tsukasa Oda, Toshiya Hayano, Hidenobu Miyaso, Nobuhiro Takahashi, Takayuki Yamashita · 2007 · Blood
  89. HDAC6 Restricts Influenza A Virus by Deacetylation of the RNA Polymerase PA Subunit
    Huan Chen, Yingjuan Qian, Xin Chen, Zhiyang Ruan, Yuetian Ye, Hongjun Chen, Lorne A. Babiuk, Yong‐Sam Jung, Jianjun Dai · 2018 · Journal of Virology
  90. Multiple Histone Deacetylases and the CREB-binding Protein Regulate Pre-mRNA 3′-End Processing
    Tadahiro Shimazu, Sueharu Horinouchi, Minoru Yoshida · 2006 · Journal of Biological Chemistry
  91. Enhancement of Stress Resilience Through Histone Deacetylase 6–Mediated Regulation of Glucocorticoid Receptor Chaperone Dynamics
    Jeanine Jochems, Sarah L. Teegarden, Yong Chen, Janette Boulden, Collin Challis, Gabriel A. Ben-Dor, Sangwon F. Kim, Olivier Berton · 2014 · Biological Psychiatry
  92. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity
    Younho Han, Hyung Min Jeong, Yun-Hye Jin, Yeon-Jin Kim, Hye Gwang Jeong, Chang‐Yeol Yeo, Kwang-Youl Lee · 2009 · Biochemical and Biophysical Research Communications
  93. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
    Laurence A. Booth, Jane L. Roberts, Cindy Sander, John Lee, John M. Kirkwood, Andrew Stewart Poklepovic, Paul Dent · 2017 · Oncotarget
  94. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation
    Zhexi Chi, Hye-Eun Byeon, Eunjeong Seo, Quynh-Anh T. Nguyen, Wonbeom Lee, Yunyong Jeong, Juyong Choi, Deepesh Pandey, Dan E. Berkowitz, Jae Hyung Kim et al. · 2019 · Pharmacological Research
  95. Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
    Michaël Broux, Cristina Prieto, Sofie Demeyer, Marlies Vanden Bempt, Llucia Albertí Servera, Inge Lodewijckx, Roel Vandepoel, Nicole Mentens, Olga Gielen, Kris Jacobs et al. · 2019 · Blood
  96. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition
    Zachariah Bertels, Harinder Singh, Isaac J. Dripps, Kendra Siegersma, Alycia F Tipton, Wiktor Witkowski, Zoie C. Sheets, Pal V. Shah, Catherine M. Conway, Elizaveta Mangutov et al. · 2021 · eLife
  97. Interactions of the Proteasomal System with Chaperones
    Marc Kästle, Tilman Grune · 2012 · Progress in molecular biology and translational science
  98. Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms
    Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben Arvid Kruse, Hans Carl Hasselbalch · 2011 · Leukemia & lymphoma/Leukemia and lymphoma
  99. HDAC6 Regulates the Chaperone‐Mediated Autophagy to Prevent Oxidative Damage in Injured Neurons after Experimental Spinal Cord Injury
    Min Su, Huaqing Guan, Fan Zhang, Yarong Gao, Xiao-Mei Teng, Wei Xin Yang · 2015 · Oxidative Medicine and Cellular Longevity
  100. Amyloid β oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner
    Yanfang Rui, James Q. Zheng · 2016 · Molecular Brain